'This is the peer reviewed version of the following article: Keane MC, Galettis RA, Mills RA, Coster DJ, Williams KA; for Contributors to the Australian Corneal Graft Registry. A comparison of endothelial and penetrating keratoplasty outcomes following failed penetrating keratoplasty: a registry study. Br J Ophthalmol. 2016 Feb 18. pii: bjophthalmol-2015-307792. doi:10.1136/ bjophthalmol-2015 which has been published in final form at after a first penetrating keratoplasty (PK), with outcomes of repeat PK after a first PK.Methods 400 eyes with a second graft (65 EK, 335 PK) performed after failure of a primary PK were identified through the Australian Corneal Graft Registry, a national prospectivelyfollowed cohort. Grafts were performed after January 2008 (follow-up of the second graft extending to 6.75 years maximum). Kaplan-Meier graft survival plots were constructed and Cox proportional hazards regression was used to identify independent risk factors for graft failure. Best corrected Snellen visual acuity (BCVA) at last follow-up was compared with pregraft acuity.Results Poorer Kaplan-Meier graft survival was observed for PK-EK compared with PK-PK (log-rank=29.66, p<0.001). Variables retained in multivariate analysis as significantly influencing survival of the second graft included graft type (PK-EK or PK-PK, p<0.001), length of survival of the previous PK (global p=0.011), graft era (global p=0.018), occurrence of rejection in the second graft (p=0.005) and a history of raised intraocular pressure at any time (p=0.048), but not indication for the first graft. BCVA improved in the majority of surviving grafts and attainment of 6/12 vision was similar for both PK-EK and PK-PK groups.Conclusions Our Registry findings suggest that repeat penetrating keratoplasty may deliver a better outcome in terms of graft survival than endokeratoplasty after a failed PK that was performed initially for keratoconus or pseudophakic bullous keratopathy. For surviving grafts, visual outcomes appear equivalent across groups.3
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.